Al Royse, chairman of the American Heart Association (AHA), is about to start his second year in his leadership position on July 1, and he has plans to make heart health more of a focus for the U.S.

According to the American Heart Association (AHA) Rapid Access Journal Report, an estimated one out of every 10 men may have a higher risk of sudden cardiac death, resulting in premature death without any warning signs.

NORD, the top independent advocacy organization dedicated to helping patients who have rare diseases, recently applauded the Senate for approving medical foods coverage in S. 2943, the National Defense Authorization Act for fiscal year 2017.

A team of researchers from the National Institutes of Health (NIH) recently released a study that suggests women who have polycystic ovary syndrome (PCOS), one of the main causes of infertility, may also have an adrenal disorder that releases too many adrenal hormones.

Leaders at the American Heart Association (AHA) recently held a forum on Capitol Hill about the progress that needs to be made for hospitals located in rural areas across the U.S.

A recent study from the ALS Association shows that choosing certain stem cells that have specific desirable properties may give patients even more therapeutic benefits than previously estimated.

Andrew Gurman, president of the American Medical Association (AMA), recently released a statement demonstrating the AMA’s support for the California insurance commissioner, who seeks to protect California from the large mergers of Anthem-Cigna and Aetna-Humana.

Dr. Andy Bindman, the director of the Agency for Healthcare Research and Quality (AHRQ), recently went to Boston to attend the 2016 AcademyHealth Annual Research Meeting (ARM).

Amgen recently announced that it has granted a platinum sponsorship to QB3@953 life science incubator to speed the creation of innovative treatments that will improve the health of patients.

Aggregating and sharing the data of millions of patients has the potential to successfully treat cancer as has never been done before, Vice President Joe Biden said during the launch of the National Cancer Moonshot Summit last week.

U.S. Sens. Christopher Murphy (D-CT) and Shelley Moore Capito (R-WV) recently sent a letter to Sens. Lamar Alexander (R-TN) and Patty Murray (D-WA), chairman and ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee respectively, to review patients’ perspectives on high out-of-pocket costs and their ability to access health care.

Leaders at the American Heart Association (AHA), the top voluntary health organization in the world that is focused on heart disease and stroke, recently granted the 2016 Gold Heart Award to leading health professionals.

Merck KGaA in Darmstadt, Germany, recently welcomed Hamilton Thorne and ZEISS as the two most recent members of the company’s Global Fertility Alliance, which already includes Illumina, Genea and Merck KGaA.

Leaders at the Epilepsy Foundation recently applauded the positive results of the phase-three clinical trial of Epidiolex, which GW Pharmaceuticals has designed to treat Lennox-Gastaut Syndrome (LGS).

Leaders with the U.S. Food and Drug Administration (FDA) Advisory Committee recently recommended Jardiance, which decreases cardiovascular death rates among adults who have type 2 diabetes and cardiovascular disease, for approval with a 12-11 vote.

The U.S. Food and Drug Administration (FDA) recently approved the Xpert Carba-R Assay test, which is designed to detect certain genetic markers that signify antibiotic-resistant bacteria within clinical specimens.

Amgen recently announced that Esteban Santos has been chosen as the company’s new executive vice president of operations, beginning on July 25 of this year.

A team of researchers and program managers has received support from the National Institutes of Health (NIH) to determine the best practices that will help decrease the heavy burden diseases place on sub-Saharan Africa.

Leaders with the U.S. Preventive Services Task Force (USPSTF) recently released a final recommendation statement as well as evidence summary to encourage adults between 50 and 75 years old to receive colorectal cancer screening.

Leaders with the European Commission (EC) recently approved an extended indication for Kyprolis (Carfilzomib), which Amgen has designed to treat patients who have relapsed multiple myeloma.